NASDAQ: ATAIAtaibeckley Inc Stock Ownership - Who owns Ataibeckley?
Insider buying vs selling
Have Ataibeckley Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christian Angermayer | Director | 2026-04-08 | 410,162 | $1.64 | $672.67kBuy |
| Christian Angermayer | Director | 2026-04-08 | 103,000 | $1.34 | $138.02kBuy |
| Christian Angermayer | Director | 2026-04-08 | 46,070 | $1.88 | $86.61kBuy |
| Kevin James Craig | Chief Medical Officer | 2026-03-20 | 100,000 | $3.55 | $355.00kSell |
| Kevin James Craig | Chief Medical Officer | 2026-03-20 | 76,224 | $1.18 | $89.94kBuy |
| Kevin James Craig | Chief Medical Officer | 2026-03-20 | 23,776 | $1.50 | $35.66kBuy |
| Apeiron Investment Group Ltd | 10% Owner | 2025-08-14 | 8,675,799 | $2.19 | $19.00MBuy |
ATAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATAI insiders and whales buy or sell their stock.
ATAI Shareholders
What type of owners hold Ataibeckley Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christian Angermayer | 15.29% | 55,770,948 | $223.08M | Insider |
| Apeiron Investment Group Ltd | 15.14% | 55,211,716 | $220.85M | Insider |
| Cosmo Feildingmellen | 2.11% | 7,702,990 | $30.81M | Insider |
| Adage Capital Partners GP LLC | 1.94% | 7,079,846 | $28.32M | Institution |
| Morgan Stanley | 1.32% | 4,820,973 | $19.28M | Institution |
| Deep Track Capital LP | 1.28% | 4,677,289 | $18.71M | Institution |
| Ark Investment Management LLC | 0.91% | 3,305,997 | $13.22M | Institution |
| Blackrock Inc | 0.77% | 2,813,208 | $11.25M | Institution |
| Foresite Capital Management VI LLC | 0.75% | 2,750,000 | $11.00M | Institution |
| Marshall Wace LLP | 0.73% | 2,675,117 | $10.70M | Institution |
ATAI vs Biotech Stocks
Ataibeckley Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.